Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy
for Patients with CAD and Diabetes and/or Left Ventricular Systolic Dysfunction (LVSD)
Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen
within a 12 month period who also have diabetes OR a current
or prior Left Ventricular Ejection Fraction (LVEF) < 40% who were prescribed ACE inhibitor or ARB therapy
"NA" is listed for group practices when the data are suppressed due to small sample size
If there is no measure value listed, it indicates the ACO did not successfully report data
Percentage of patients ages 18 to 75 years of age with diabetes mellitus
and ischemic vascular disease with documented daily aspirin use during the measurement year
unless contraindicated
If the measure has a value of "NA," it indicates that data are suppressed due to small sample size
Percentage of patients with a diagnosis of diabetes who indicated they were tobacco non-users
Percentage of patients ages 18 to 75 years of age with diabetes mellitus who had a blood pressure < 140/90 mmHg
Proportion of patients ages 18 to 75 years of age with diabetes mellitus who had HbA1c < 8.0 percent
Hemoglobin A1c Control
Legal Business Name (LBN)
CMS Certification Number (CCN)
Group Practice Reporting Option (GRPO)
Accountable Care Organization (ACO)
Physician Quality Reporting System (PQRS)
by Jean Roth , jroth@nber.org , 24 Jun 2014